Thymalfasin (CAS 62304-98-7) – Wholesale & Research Grade
Thymalfasin is a polypeptide.
Research Context
Thymalfasin, also known as Thymosin alpha 1, is a synthetic peptide derived from the thymus gland that has garnered significant interest in biomedical research due to its immunomodulatory properties. As a promising therapeutic agent, Thymalfasin is being explored for its potential applications in enhancing immune responses, particularly in the treatment of infectious diseases, cancer, and autoimmune disorders.
Research Applications
The primary application of Thymalfasin lies in its role as an immune enhancer. It is being studied for its efficacy in combination therapies for various types of cancer, where enhancing the body's immune response can improve patient outcomes. Additionally, Thymalfasin has shown potential in mitigating the effects of viral infections, including hepatitis B and C, by promoting T-cell activity and modulating cytokine production.
Mechanism of Action
Thymalfasin operates by stimulating T-cell proliferation and differentiation, thereby enhancing the adaptive immune response. It acts on various immune cells, including dendritic cells and macrophages, promoting their maturation and function. This immunomodulatory action not only boosts the body’s defense mechanisms against pathogens but also aids in the recovery of immune function in immunocompromised patients.
Solubility and Storage
Thymalfasin is soluble in water, making it suitable for various pharmaceutical formulations. For optimal preservation, it should be stored in a dry, cool place, protected from light. It is advisable to keep the peptide at low temperatures to maintain its stability and efficacy over time.
Future Research Directions
Ongoing research is focused on exploring Thymalfasin's full therapeutic potential, including its use in vaccine adjuvants and its role in enhancing responses to newly emerging infections. Investigations into its long-term safety profile and efficacy in diverse populations are critical for its future applications in clinical settings. The development of novel delivery systems may also enhance its bioavailability and therapeutic impact.
| CAS Number | 62304-98-7 |
|---|---|
| Formula | C129H215N33O55 |
| Mol. Weight | 3108.3 g/mol |
| IUPAC Name | (4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-... |
| Grade | HPLC ≥98% |
Synthesis & Storage
Thymalfasin is supplied as a lyophilized powder to ensure stability during transit.
For long-term storage of CAS 62304-98-7, we recommend maintaining at -20°C.
Researchers must reconstitute this peptide with bacteriostatic water or sterile solvent only when ready for use.
Quality Control: All batches undergo rigorous HPLC purity testing (≥98%) prior to dispatch from our USA fulfillment center.